CTMC, a joint venture between MD Anderson Cancer Center and Resilience, has entered a partnership with Syenex to advance the ...

Part B of the LIGHTHOUSE study will enroll adults and children. DURHAM, N.C., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene therapy company focused ...

The securities described above are being offered by uniQure pursuant to its automatically effective shelf registration statement on Form S-3 (File No. 333-284168) filed with the U.S. Securities ...

One drive is the rising prevalence of chronic diseases like cancer and diabetes. Increased investment in research and development is accelerating the discovery and refinement of cell and gene ...

UC Davis Health has premiered a new documentary on a family’s urgent journey across the globe to get their toddler in a clinical trial for patients with Duchenne Muscular Dystrophy, or DMD.

A study published in Human Gene Therapy has involved the generation of a human monoclonal antibody (mAb) directed against ...

National Resilience acquired the Triangle office in 2021. Since then, funding for gene therapy solutions has fallen.

The company is trying to develop a one-time treatment for forms of heart disease that afflict more than 1 million people in ...

The three-year partnership is another example of Vertex’s interest in improving on Casgevy, its CRISPR medicine for sickle cell and beta thalassemia.

WuXi AppTec, the Shanghai-based biotech giant, has sold its South Philly-based WuXi Advanced Therapies contract manufacturing ...

We recently compiled a list of the 15 Small-Cap Stocks Poised to Outperform in 2025. In this article, we are going to take a ...

Gene therapy firm Capsida Biotherapeutics is advancing the first of its AbbVie-partnered neurodegenerative disease therapies ...